BridgeBio Oncology Therapeutics, Inc. (BBOT)

BBOT Statistics

Total Valuation

BBOT has a market cap or net worth of $727.50 million. The enterprise value is $304.80 million.

Market Cap	727.50M
Enterprise Value	304.80M

Important Dates

The last earnings date was Thursday, March 5, 2026, after market close.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

BBOT has 80.03 million shares outstanding. The number of shares has increased by 241,276.23% in one year.

Current Share Class	80.03M
Shares Outstanding	80.03M
Shares Change (YoY)	+241,276.23%
Shares Change (QoQ)	+83.92%
Owned by Insiders (%)	5.66%
Owned by Institutions (%)	40.69%
Float	31.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.77
P/TBV Ratio	1.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.34, with a Debt / Equity ratio of 0.01.

Current Ratio	12.34
Quick Ratio	12.15
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.23% and return on invested capital (ROIC) is -32.63%.

Return on Equity (ROE)	-48.23%
Return on Assets (ROA)	-29.75%
Return on Invested Capital (ROIC)	-32.63%
Return on Capital Employed (ROCE)	-35.28%
Weighted Average Cost of Capital (WACC)	5.77%
Revenue Per Employee	n/a
Profits Per Employee	-$1.65M
Employee Count	92
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.21% in the last 52 weeks. The beta is 0.28, so BBOT's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	-15.21%
50-Day Moving Average	11.20
200-Day Moving Average	11.19
Relative Strength Index (RSI)	34.58
Average Volume (20 Days)	250,239

Short Selling Information

The latest short interest is 2.33 million, so 2.91% of the outstanding shares have been sold short.

Short Interest	2.33M
Short Previous Month	2.34M
Short % of Shares Out	2.91%
Short % of Float	7.47%
Short Ratio (days to cover)	2.07

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-145.82M
Pretax Income	-134.04M
Net Income	-134.04M
EBITDA	-145.54M
EBIT	-145.82M
Earnings Per Share (EPS)	-$4.30

Balance Sheet

The company has $425.46 million in cash and $2.77 million in debt, with a net cash position of $422.69 million or $5.28 per share.

Cash & Cash Equivalents	425.46M
Total Debt	2.77M
Net Cash	422.69M
Net Cash Per Share	$5.28
Equity (Book Value)	411.10M
Book Value Per Share	5.14
Working Capital	397.36M

Cash Flow

In the last 12 months, operating cash flow was -$113.89 million and capital expenditures -$606,000, giving a free cash flow of -$114.50 million.

Operating Cash Flow	-113.89M
Capital Expenditures	-606,000
Free Cash Flow	-114.50M
FCF Per Share	-$1.43

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BBOT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-241,276.23%
Shareholder Yield	-241,276.23%
Earnings Yield	-18.43%
FCF Yield	-15.74%

Analyst Forecast

The average price target for BBOT is $24.00, which is 164.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$24.00
Price Target Difference	164.03%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2